CHINA AOYUAN (03883): Completed director training.
China Aoyuan (03883) announced that the Hong Kong Stock Exchange (HKEX) issued a Disciplinary Action Statement on January 13, 2026 regarding disciplinary actions taken by the HKEX against the former directors and current directors of the company.
CHINA AOYUAN (03883) announcement, mentioned the disciplinary action statement issued by the Hong Kong Stock Exchange (HKEX) on January 13, 2026, regarding disciplinary actions taken against former directors and current directors of the company.
As stated in the statement, HKEX has instructed Mr. Guo Ziwen, Mr. Zhang Guoqiang, and Mr. Li Jingbo to complete 17 hours of training on regulatory and legal issues, as well as compliance matters under the Listing Rules within 90 days from the date of the statement, including 2 hours on Listing Rule 2.13 and 3 hours each on director duties and the Corporate Governance Code (Director Training).
Other former directors of the company (Mr. Zhang Jun, Mr. Ma Jun, Mr. Chen Jiayang, and Mr. Hu Jiang) have also been instructed to undergo 17 hours of director training as a prerequisite for future appointments as directors of any listed or prospective listed companies on HKEX.
The company confirms that Mr. Guo, Mr. Zhang, Mr. Li, Mr. Zhang Jun, Mr. Ma, Mr. Chen, and Mr. Hu have completed the 17 hours of director training provided by an HKEX-approved training institution within the specified period, and the company has provided HKEX with comprehensive compliance certificates issued by the training institution.
Related Articles

BAOZUN-W (09991) released its annual performance with a net loss of 242 million yuan, a year-on-year increase of 30.72%.

On March 25th, NETEASE MUSIC (09899) spent HK$14.99 million to repurchase 115,000 shares.

Takeda Pharmaceutical Co. Ltd. Sponsored ADR (TAK.US) plans to allocate 150 billion yen in restructuring costs to drive cost reduction and efficiency improvements with AI.
BAOZUN-W (09991) released its annual performance with a net loss of 242 million yuan, a year-on-year increase of 30.72%.

On March 25th, NETEASE MUSIC (09899) spent HK$14.99 million to repurchase 115,000 shares.

Takeda Pharmaceutical Co. Ltd. Sponsored ADR (TAK.US) plans to allocate 150 billion yen in restructuring costs to drive cost reduction and efficiency improvements with AI.

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


